It is increasingly becoming clear that the AnxA6 expression status varies greatly in breast cancer cells as tumor cells with mesenchymal-like phenotypes express higher levels of the protein compared to those with basal-like morphology [19,20]. The gene discussed is ANXA6; the disease is breast carcinoma.